[Clinical study on aztreonam in pediatrics]. 1985

M Niino, and K Kida, and H Matsuda, and M Murase

Efficacy and safety of aztreonam (AZT) for 31 cases of infections of children were studied with the following results. Clinical efficacy of AZT for 22 respiratory tract infections, 5 urinary tract infections and 2 gastrointestinal infections was "excellent" for 19 cases (65.5%), "good" for 9 cases (31.0%) and "poor" for 1 case (3.4%) with an overall effective rate of 96.6%. Microbiological effect of AZT for 19 isolated strains (15 cases) was 100% in disappearance of the Gram-negative bacteria and 89.5% on the whole. With regard to side effect of AZT in 31 cases, there was a slight elevation of GPT in 1 case and eosinophilia in 2 cases. It was considered from the above results that AZT is a useful and safe antibiotic for infections of children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004751 Enteritis Inflammation of any segment of the SMALL INTESTINE. Enteritides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Niino, and K Kida, and H Matsuda, and M Murase
November 1985, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
November 1985, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
November 1985, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
November 1985, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
May 1988, The Pediatric infectious disease journal,
M Niino, and K Kida, and H Matsuda, and M Murase
January 1985, Giornale italiano di chemioterapia,
M Niino, and K Kida, and H Matsuda, and M Murase
December 1985, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
May 1990, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
November 1992, The Japanese journal of antibiotics,
M Niino, and K Kida, and H Matsuda, and M Murase
November 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!